Fascination About sirpiglenastat clinical trial
“This certain prodrug structure made DON qualified to its supposed place (tumor) and also have a lot less of an impact on wholesome cells in other places.”
It's got anticancer outcomes by immediately concentrating on tumor metabolism and at the same time inducing a strong antitumo